Vascular endothelial growth factor as an age-dependent prognostic factor in gastric cancer patients

American Journal of Surgery

Volumn 184, Issue 5, 2002, Pages 460-464

  Minato, Eiji ^a   Miki, Chikao ^a   Tanaka, Kouji ^a   Kobayashi, Minako ^a   Mohri, Yasuhiko ^a   Tonouchi, Hitoshi ^a   Kuribayashi, Kagemasa ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Elderly patient; Gastric carcinoma; Vascular endothelial growth factor

Indexed keywords

GLUCOSE; OXYGEN; VASCULOTROPIN;

ADULT; AGE; AGED; ARTICLE; BLOOD OXYGENATION; CANCER GROWTH; CANCER PATIENT; CANCER TISSUE; CONTROLLED STUDY; ENERGY RESOURCE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL DEFICIENCY; OXYGEN SUPPLY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH CARCINOMA; STOMACH MUCOSA; TISSUE LEVEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; FEMALE; GASTRIC MUCOSA; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036845451     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(02)01006-1     Document Type: Article

References (22)

1. Hirayama R., Takemura K., Nihei Z., et al. Differential effect of host microenvironment and systemic humoral factors on the implantation and the growth rate of metastatic tumor in parabiotic mice constructed between young and old mice. Mech Ageing Develp. 71:1993;213-221.
2. Kreisle R.A., Stebler B.A., Ershler W.B. Effect of host age on tumor-associated angiogenesis in mice. J Natl Cancer Inst. 82:1990;44-47.
3. Pili R., Guo Y., Chang J., et al. Altered angiogenesis underlying age-dependent changes in tumor growth. J Natl Cancer Inst. 86:1994;1303-1314.
4. Leung D.W., Cachianes G., Kuang W.J., et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 142:1989;273-283.
5. Connolly D.T., Heuvelman D.M., Nelson R., et al. Tumor vascular permeability factors stimulates endothelial cell growth and angiogenesis. J Clin Invest. 84:1989;1470-1478.
6. Maeda K., Chung Y.S., Ogawa Y., et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer. 77:1996;858-863.
7. Yonemura Y., Endo Y., Fujita H., et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res. 5:1999;1823-1829.
8. Maehara Y., Kabashima A., Koga T., et al. Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma. Surgery. 128:2000;408-416.
9. Ikeguchi M., Oka S., Saito H., et al. The expression of vascular endothelial growth factor and proliferative activity of cancer cells in gastric cancer. Langenbeck's Arch Surg. 384:1999;264-270.
10. Nomura M., Yamagishi S., Harada S., et al. Possible participation of autocrine and paracrine vascular endothelial growth factor in hypoxia-induced proliferation of endothelial cells and pericytes. J Biol Chem. 270:1995;28316-28324.
11. Levy A.P., Levy N.S., Loscalzo J., et al. Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res. 76:1995;758-766.
12. Ladoux A., Frelin C. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun. 195:1995;1005-1010.
13. Waltenberger J., Mayer U., Pentz S., et al. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation. 94:1996;1647-1652.
14. Satake S., Kuzuya M., Miura H., et al. Up-regulation of vascular endothelial growth factor in response to glucose deprivation. Biol Cell. 90:1998;161-168.
15. Ro J.Y., Tetu B., Ayala A.G., et al. Small cell carcinoma of the prostate. Cancer. 59:1987;977-982.
16. Obermair A., Tempfer C., Hefler L., et al. Concentration of vascular endothelial growth factor (VEGF) in the sera of patients with suspected ovarian cancer. Br J Cancer. 77:1998;1870-1874.
17. Mattern J., Koomagi R., Volm M. Vascular endothelial growth factor expression and angiogenesis in non-small cell lung carcinoma. Int J Oncol. 6:1995;1059-1062.
18. Cohen T., Nahari D., Cerem L.W., et al. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem. 271:1996;736-741.
19. Liu X, Lin CS, Graziottin T, et al. Vascular endothelial growth factor promotes proliferation and migration of cavernous smooth muscle cells. J Urol 2001;166:354-60.
20. Ito H., Miki C. Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients. Scand J Gastroenterol. 34:1999;1139-1143.
21. Wakuda R., Miki C., Kusunoki M. Autoreactivity against interleukin 6 as a risk factor in elderly patients with colorectal carcinoma. Arch Surg. 136:2001;1274-1279.
22. Kinoshita T., Ito H., Miki C. Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma. Cancer. 85:1999;2526-2531.